Steve Pakola

Company: REGENXBIO

Job title: Chief Medical Officer

Seminars:

Utilizing Gene Therapy to Induce Long-Term Treatment of Wet AMD & Diabetic Retinopathy 9:55 am

Outline the RGX-314 gene therapy program Discussing why suprachoroidal/subretinal delivery are optimal for this treatment Reviewing the current clinical data from Phase III clinical trialsRead more

day: Day One